APA (7th ed.) Citation

T, G., Y, S., P, L., D, L., Q, G., & J, L. (2025). CDK4/6 inhibitors in breast cancer therapy: Mechanisms of drug resistance and strategies for treatment. Frontiers in pharmacology, 16, 1549520. https://doi.org/10.3389/fphar.2025.1549520

Chicago Style (17th ed.) Citation

T, Gao, Sun Y, Leng P, Liu D, Guo Q, and Li J. "CDK4/6 Inhibitors in Breast Cancer Therapy: Mechanisms of Drug Resistance and Strategies for Treatment." Frontiers in Pharmacology 16 (2025): 1549520. https://doi.org/10.3389/fphar.2025.1549520.

MLA (9th ed.) Citation

T, Gao, et al. "CDK4/6 Inhibitors in Breast Cancer Therapy: Mechanisms of Drug Resistance and Strategies for Treatment." Frontiers in Pharmacology, vol. 16, 2025, p. 1549520, https://doi.org/10.3389/fphar.2025.1549520.